Midatech Pharma PLC Holding(s) in Company (1324O)

TIDMMTPH

RNS Number : 1324O

Midatech Pharma PLC

02 November 2016

 
 For filings with the FCA 
  include the annex 
 For filings with issuer exclude 
  the annex 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                              MIDATECH PHARMA PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
------------------------------------------------------  ------------------------ 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
-------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                      ü 
-------------------------------------------------------  ----------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
-------------------------------------------------------  ----------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
-------------------------------------------------------  ----------------------- 
 An event changing the breakdown of voting rights                 ü 
-------------------------------------------------------  ----------------------- 
 Other (please 
  specify): 
-----------------------------------------------------    ----------------------- 
 3. Full name of person(s)                               HARGREAVE HALE LIMITED 
  subject to the 
  notification obligation: 
  (iii) 
------------------------------------------------------  ------------------------ 
 4. Full name of shareholder(s)                           DISCRETIONARY CLIENTS 
  (if different from 3.):(iv) 
------------------------------------------------------  ------------------------ 
 5. Date of the transaction                                  31 OCTOBER 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
------------------------------------------------------  ------------------------ 
 6. Date on which issuer                                    01 NOVEMBER 2016 
  notified: 
------------------------------------------------------  ------------------------ 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                               5% 
------------------------------------------------------  ------------------------ 
 
 
 
 8. Notified details: 
----------------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
----------------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                 Resulting situation after the triggering 
  of             to the triggering                  transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  ---------------------------------  --------------------------------------------------------------------------- 
                Number           Number            Number                         Number of                % of voting 
                 of               of                of shares                      voting                   rights (x) 
                 Shares           Voting                                           rights 
                                  Rights 
-------------  ---------------  ----------------  -----------------------------  -----------------------  ------------------- 
                                                   Direct         Indirect        Direct     Indirect      Direct    Indirect 
                                                                                   (xi)       (xii) 
-------------      -----------      ------------  -------------  --------------  ---------  ------------  --------  --------- 
 GB00BRTL9B63   1,431,086        1,431,086                        2,484,211                  2,484,211               5.1011% 
               ---------------  ----------------  -------------  --------------  ---------  ------------  --------  --------- 
 
 
 B: Qualifying Financial Instruments 
----------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration       Exercise/                        Number of voting                     % of voting 
 financial           date             Conversion                       rights that                          rights 
 instrument          (xiii)           Period (xiv)                     may be 
                                                                       acquired if 
                                                                       the 
                                                                       instrument 
                                                                       is 
                                                                       exercised/ 
                                                                       converted. 
-----------------  ---------------  -------------------------------  -----------------------------------  ------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise         Expiration        Exercise/      Number of voting           % of voting 
 financial         price            date              Conversion     rights instrument          rights (xix, 
 instrument                         (xvii)            period         refers to                  xx) 
                                                      (xviii) 
---------------  ---------------  ----------------  -------------  -------------------------  ------------------------------- 
                                                                                               Nominal               Delta 
---------------  ---------------  ----------------  -------------  -------------------------  --------------------  --------- 
 
 
 Total (A+B+C) 
----------------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                            Percentage of voting rights 
-----------------------------------------------------------------  ---------------------------------------------------------- 
 
   2,484,211                                                        5.1011% 
-----------------------------------------------------------------  ---------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
------------------------------------------------------------------------------------------------------- 
 2,253,125 of these shares are held for a unit trust 
  operated by Marlborough Fund Managers Ltd, for whom 
  Hargreave Hale Ltd manages the investments on a discretionary 
  basis. The remaining shares are held for other discretionary 
  clients. 
 
 Proxy Voting: 
------------------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
----------------------------------------------------------------  ------------------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
----------------------------------------------------------------  ------------------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
----------------------------------------------------------------  ------------------------------------- 
 
                                                                   The change in the percentage 
  13. Additional information:                                      of shares held is entirely 
                                                                   due to participation in the 
                                                                   open offer by Midatech Pharma 
                                                                   Plc, the shares from which 
                                                                   were admitted to AIM on 31/10/2016. 
----------------------------------------------------------------  ------------------------------------- 
 14. Contact name:                                                 David Clueit, 
                                                                    Hargreave Hale Ltd 
----------------------------------------------------------------  ------------------------------------- 
 15. Contact telephone number:                                     01253 754739 
----------------------------------------------------------------  ------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBTBLTMBIMMLF

(END) Dow Jones Newswires

November 02, 2016 05:51 ET (09:51 GMT)